Background: Very short-term outcomes are reported in reports on very high-risk morbidly obese patients undergoing laparoscopic sleeve gastrectomy (LSG). Nevertheless, the short- and mid-term outcomes remain unclear. Aim: To evaluate our experience and outcomes with LSG as an independent bariatric operation. Methods: This study was conducted at Department of General Surgery, Tobruk Medical Center, Libya during the period from 1/2022 to 6/2022 on patients with a BMI >40 kg/m2 without comorbidities or with a BMI >35 kg/m2 with at least one obesity related comorbidity qualify for bariatric surgery, which includes LSG. All patients underwent a preoperative medical evaluation, a detailed psychological assessment, relevant laboratory/radiologic testing, and esophagogastroduodenoscopy. Patients were followed up for 12 months. Results: The mean excess body weight loss was 22.5%, 33.5%, 41.2%, 49.7% and 61.3% at 1, 3, 6, 9, 12 months postoperatively, respectively. No deaths occurred in our cases. 2% conversion rate were occurred. A return to the operating room was needed in only two patients (4%). Major complications, specifically staple line leak, bleeding, and gastric sleeve stricture, were not seen in our cases. Conclusion: Satisfactory weight loss outcomes and low complication rates were observed after LSG. In our experience LSG is technically simple, safe, and effective to serve as a definitive procedure for morbid obesity.